Blar i HV - Institutt for naturvitenskapelige helsefag på emneord "Breast neoplasms"
Viser treff 1-4 av 4
-
Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program
(Cancer;119(17), Journal article; Peer reviewed, 2013-05-29)BACKGROUND The Norwegian Breast Cancer Screening Program started in 1996. To the authors' knowledge, this is the first report using individual-based data on invitation and participation to analyze breast cancer mortality ... -
Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission
(Book; Peer reviewed; Research report, 2019-08-16)Breast cancer can be treated with chemotherapy, hormone therapy and radiation, or a combination of these to prevent the spread of cancer cells, after surgical removal of the tumor. When assessing whether a patient should ... -
Radiological review of prior screening mammograms of screen-detected breast cancer
(European Radiology;, Journal article; Peer reviewed, 2020-10-01)Objective: To perform a radiological review of mammograms from prior screening and diagnosis of screen-detected breast cancer in BreastScreen Norway, a population-based screening program. Methods: We performed a ... -
Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review
(European Radiology;, Journal article; Peer reviewed, 2020-11-12)Objectives: “True” breast cancers, defined as not being visible on prior screening mammograms, are expected to be more aggressive than “missed” cancers, which are visible in retrospect. However, the evidence to support ...